Quick Answer
Jaguar Health, Inc. reported R&D Expense of $16.54 million for fiscal year 2024.
Jaguar Health, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2024 | $16.54M | -11.0% |
| 2023 | $18.60M | +5.4% |
| 2022 | $17.65M | +17.0% |
| 2021 | $15.08M | +135.1% |
| 2020 | $6.41M | +10.2% |
| 2019 | $5.82M | +12.9% |
| 2018 | $5.15M | +20.7% |
| 2017 | $4.27M | -40.8% |
| 2016 | $7.21M | +11.3% |
| 2015 | $6.48M | +53.4% |
| 2014 | $4.22M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.66M | -9.5% | +12.0% |
| June 30, 2025 | $3.27M | -10.6% | -12.5% |
| March 31, 2025 | $3.73M | -13.5% | -7.7% |
| September 30, 2024 | $4.04M | -33.5% | +10.7% |
| June 30, 2024 | $3.65M | -14.6% | -15.3% |
| March 31, 2024 | $4.31M | -9.7% | -29.1% |
| September 30, 2023 | $6.08M | +2.4% | +42.2% |
| June 30, 2023 | $4.28M | +74.5% | -10.4% |
- Jaguar Health, Inc. showed a decrease of -11.0% in R&D Expense compared to the prior fiscal year.
- Over the 2014–2024 period, Jaguar Health, Inc.’s r&d expense has grown by 292.0% (from $4.22 million to $16.54 million).
- The most recent figure is from Jaguar Health, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: